Clinical Trial Update: Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated autologous dendritic cell vaccine for chronic hepatitis C infection; the study is completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Diseases

Drugs mentioned

• Autologous dendritic cell vaccine (dendritic cell vaccine)

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Hepatitis C, Chronic, Liver Diseases | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-10